Log in

New York visits Toronto after Bjorkstrand's 2-goal game

New York Rangers (7-3-1, in the Metropolitan Division) vs. Toronto Maple Leafs (5-4-2, in the Atlantic Division)

Toronto; Thursday, 7 p.m. EDT

BOTTOM LINE: The New York Rangers visit the Toronto Maple Leafs after Oliver Bjorkstrand's two-goal game against the Anaheim Ducks in the Rangers' 5-2 win.

You must be a member to read this story.

Join our family of readers starting at $5 for your first month and support local, unbiased journalism.


Already have an account? Log in to continue.

Otherwise, follow the link below to join.

Please log in to continue

Log in
I am anchor

New York visits Toronto after Bjorkstrand's 2-goal game

Posted

New York Rangers (7-3-1, in the Metropolitan Division) vs. Toronto Maple Leafs (5-4-2, in the Atlantic Division)

Toronto; Thursday, 7 p.m. EDT

BOTTOM LINE: The New York Rangers visit the Toronto Maple Leafs after Oliver Bjorkstrand's two-goal game against the Anaheim Ducks in the Rangers' 5-2 win.

Toronto has a 5-4-2 record overall and a 3-3-1 record on its home ice. The Maple Leafs are seventh in the league serving 9.8 penalty minutes per game.

New York has gone 1-3-1 on the road and 7-3-1 overall. The Rangers have a 5-2-0 record when scoring a power-play goal.

The teams meet Thursday for the first time this season.

INJURIES: Maple Leafs: John Tavares: out (lower body), Dakota Joshua: out (abdomen), Jake McCabe: day to day (face), Cade Webber: out (elbow), Elvis Merzlikins: out (shoulder), Max Domi: out (back), Miles Wood: out (undisclosed), Chris Tanev: out (upper body), William Villeneuve: out (knee).

Rangers: Joseph Veleno: out (lower-body), Igor Shesterkin: out for season (lower body), Joonas Korpisalo: out (lower-body), Aidan Thompson: out (undisclosed), Adam Sykora: out (lower-body).

___

The Associated Press created this story using technology provided by Data Skrive and data from Sportradar.

Share with others


Have an opinion on this story? Click here to send a letter to our editors.

Comments

No comments on this item Please log in to comment by clicking here